Targeting gene-fibroblast interaction offers hope for treatment-resistant colon cancer

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 2, entitled, “PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.”

U.S. News Releases ‘Best Children’s Hospitals’ Amid Ongoing Criticism

As U.S. News & World Report rolled out its annual list of “Best Children’s Hospitals,” the outlet also received new pushback on its rankings. On

June 22, 2023

Novel tool uncovers new cell types in the visual system of flies

New York University researchers have discovered new cell types in the visual system of flies, made possible by their creation of a tool that finds

August 1, 2023

Is CG Oncology’s IPO a benchmark for a better year in public offerings?

NEW YORK — CG Oncology rang the Nasdaq opening bell on Thursday morning, marking a rare sight for biotechs over the past two years as

January 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.